Herpes keratitis

Progress in Retinal and Eye Research

Volumn 32, Issue 1, 2013, Pages 88-101

  Rowe, A M ^a   St Leger, A J ^a   Jeon, S ^a   Dhaliwal, D K ^a   Knickelbein, J E ^a   Hendricks, R L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cornea; Herpes simplex virus 1; Keratitis

Indexed keywords

ANTIVIRUS AGENT; STEROID;

ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CORNEA EPITHELIUM; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUBRETINAL NEOVASCULARIZATION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; VISUAL IMPAIRMENT;

ANTIVIRAL AGENTS; CORNEA; DNA, VIRAL; HERPESVIRUS 1, HUMAN; HUMANS; KERATITIS, HERPETIC;

EID: 84871389032     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.08.002     Document Type: Review

References (215)

1. Allan R.S., Smith C.M., Belz G.T., van Lint A.L., Wakim L.M., Heath W.R., Carbone F.R. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 2003, 301:1925-1928.
2. Allan R.S., Waithman J., Bedoui S., Jones C.M., Villadangos J.A., Zhan Y., Lew A.M., Shortman K., Heath W.R., Carbone F.R. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006, 25:153-162.
3. Ambati B.K., Anand A., Joussen A.M., Kuziel W.A., Adamis A.P., Ambati J. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest. Ophthalmol. Vis. Sci. 2003, 44:590-593.
4. Ambati B.K., Nozaki M., Singh N., Takeda A., Jani P.D., Suthar T., Albuquerque R.J., Richter E., Sakurai E., Newcomb M.T., et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006, 443:993-997.
5. Avery A.C., Zhao Z.S., Rodriguez A., Bikoff E.K., Soheilian M., Foster C.S., Cantor H. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature 1995, 376:431-434.
6. Banerjee K., Biswas P.S., Kim B., Lee S., Rouse B.T. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J. Immunol. 2004, 172:1237-1245.
7. Banerjee K., Biswas P.S., Kumaraguru U., Schoenberger S.P., Rouse B.T. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. J. Immunol. 2004, 173:7575-7583.
8. Bedoui S., Whitney P.G., Waithman J., Eidsmo L., Wakim L., Caminschi I., Allan R.S., Wojtasiak M., Shortman K., Carbone F.R., et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 2009, 10:488-495.
9. Bertke A.S., Swanson S.M., Chen J., Imai Y., Kinchington P.R., Margolis T.P. A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro. J. Virol. 2011, 85:6669-6677.
10. Biswas P.S., Rouse B.T. Early events in HSV keratitis-setting the stage for a blinding disease. Microbe. Infect./Inst. Pasteur 2005, 7:799-810.
11. Bloom D.C., Giordani N.V., Kwiatkowski D.L. Epigenetic regulation of latent HSV-1 gene expression. Biochim. Biophys. Acta 2010, 1799:246-256.
12. Blyth W.A., Hill T.J., Field H.J., Harbour D.A. Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. J. Gen. Virol. 1976, 33:547-550.
13. Bonneau R.H. Stress-induced effects on integral immune components involved in herpes simplex virus (HSV)-specific memory cytotoxic T lymphocyte activation. Brain Behav. Immun. 1996, 10:139-163.
14. Bonneau R.H., Sheridan J.F., Feng N.G., Glaser R. Stress-induced effects on cell-mediated innate and adaptive memory components of the murine immune response to herpes simplex virus infection. Brain Behav. Immun. 1991, 5:274-295.
15. Bonneau R.H., Sheridan J.F., Feng N., Glaser R. Stress-induced modulation of the primary cellular immune response to herpes simplex virus infection is mediated by both adrenal-dependent and independent mechanisms. J. Neuroimmunol. 1993, 42:167-176.
16. Bonneau R.H., Zimmerman K.M., Ikeda S.C., Jones B.C. Differential effects of stress-induced adrenal function on components of the herpes simplex virus-specific memory cytotoxic T-lymphocyte response. J. Neuroimmunol. 1998, 82:191-199.
17. Bouley D.M., Kanangat S., Wire W., Rouse B.T. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J. Immunol. 1995, 155:3964-3971.
18. Brissette-Storkus C.S., Reynolds S.M., Lepisto A.J., Hendricks R.L. Identification of a novel macrophage population in the normal mouse corneal stroma. Invest. Ophthalmol. Vis. Sci. 2002, 43:2264-2271.
19. Carr D.J., Ash J., Lane T.E., Kuziel W.A. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J. Gen. Virol. 2006, 87:489-499.
20. Carr D.J., Wuest T., Ash J. An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3. J. Interferon. Cytokine. Res. 2008, 28:245-251.
21. Chang E.J., Dreyer E.B. Herpesvirus infections of the anterior segment. Int. Ophthalmol. Clin. 1996, 36:17-28.
22. Chen W., Tang Q., Hendricks R.L. Ex vivo model of leukocyte migration into herpes simplex virus-infected mouse corneas. J. Leukoc. Biol. 1996, 60:167-173.
23. Cheng H., Tumpey T.M., Staats H.F., van Rooijen N., Oakes J.E., Lausch R.N. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest. Ophthalmol. Vis. Sci. 2000, 41:1402-1409.
24. Chinnery H.R., Pearlman E., McMenamin P.G. Cutting edge: membrane nanotubes in vivo: a feature of MHC class II+ cells in the mouse cornea. J. Immunol. 2008, 180:5779-5783.
25. Chodosh J., Banks M.C., Stroop W.G. Rose bengal inhibits herpes simplex virus replication in vero and human corneal epithelial cells in vitro. Invest. Ophthalmol. Vis. Sci. 1992, 33:2520-2527.
26. Cliffe A.R., Garber D.A., Knipe D.M. Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J. Virol. 2009, 83:8182-8190.
27. Conrady C.D., Jones H., Zheng M., Carr D.J. A functional type I interferon pathway drives resistance to cornea herpes simplex virus type 1 infection by recruitment of leukocytes. J. Biomed. Res. 2011, 25:111-119.
28. Conrady C.D., Zheng M., Fitzgerald K.A., Liu C., Carr D.J. Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16. Mucosal Immunol. 2012, 5:173-183.
29. Corey L., Langenberg A.G., Ashley R., Sekulovich R.E., Izu A.E., Douglas J.M., Handsfield H.H., Warren T., Marr L., Tyring S., et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV vaccine study group. J. Am. Med. Assoc. 1999, 282:331-340.
30. Cremer K.J., Mackett M., Wohlenberg C., Notkins A.L., Moss B. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 1985, 228:737-740.
31. Croen K.D. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 1993, 91:2446-2452.
32. Darougar S., Hunter P.A., Viswalingam M., Gibson J.A., Jones B.R. Acute follicular conjunctivitis and keratoconjunctivitis due to herpes simplex virus in London. Br. J. Ophthalmol. 1978, 62:843-849.
33. Darougar S., Wishart M.S., Viswalingam N.D. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br. J. Ophthalmol. 1985, 69:2-6.
34. Decman V., Kinchington P.R., Harvey S.A., Hendricks R.L. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 2005, 79:10339-10347.
35. Deshpande S.P., Lee S., Zheng M., Song B., Knipe D., Kapp J.A., Rouse B.T. Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. J. Virol. 2001, 75:3077-3088.
36. Divito S.J., Hendricks R.L. Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest. Ophthalmol. Vis. Sci. 2008, 49:1488-1495.
37. Donaghy H., Bosnjak L., Harman A.N., Marsden V., Tyring S.K., Meng T.C., Cunningham A.L. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J. Virol. 2009, 83:1952-1961.
38. Doymaz M.Z., Rouse B.T. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest. Ophthalmol. Vis. Sci. 1992, 33:2165-2173.
39. Du T., Zhou G., Roizman B. HSV-1 gene expression from reactivated ganglia is disordered and concurrent with suppression of latency-associated transcript and miRNAs. Proc. Natl. Acad. Sci. U S A 2011, 108:18820-18824.
40. Elliott J.M., Yokoyama W.M. Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol. 2011, 32:364-372.
41. Farrell M.J., Dobson A.T., Feldman L.T. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. U S A 1991, 88:790-794.
42. Feldman L.T., Ellison A.R., Voytek C.C., Yang L., Krause P., Margolis T.P. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. U S A 2002, 99:978-983.
43. Fenton R.R., Molesworth-Kenyon S., Oakes J.E., Lausch R.N. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest. Ophthalmol. Vis. Sci. 2002, 43:737-743.
44. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., Perricaudet M., Tursz T., Maraskovsky E., Zitvogel L. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 1999, 5:405-411.
45. Ficker L.A., Kirkness C.M., Rice N.S., Steele A.D. The changing management and improved prognosis for corneal grafting in herpes simplex keratitis. Ophthalmology 1989, 96:1587-1596.
46. Frank G.M., Buela K.A., Maker D.M., Harvey S.A., Hendricks R.L. Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J. Immunol. 2012, 188:1350-1359.
47. Freeman M.L., Sheridan B.S., Bonneau R.H., Hendricks R.L. Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections. J. Immunol. 2007, 179:322-328.
48. Fukuda M., Deai T., Higaki S., Hayashi K., Shimomura Y. Presence of a large amount of herpes simplex virus genome in tear fluid of herpetic stromal keratitis and persistent epithelial defect patients. Semin. Ophthalmol. 2008, 23:217-220.
49. Gamba G., Cavalieri H., Courreges M.C., Massouh E.J., Benencia F. Early inhibition of nitric oxide production increases HSV-1 intranasal infection. J. Med. Virol. 2004, 73:313-322.
50. Gangappa S., Babu J.S., Thomas J., Daheshia M., Rouse B.T. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J. Immunol. 1998, 161:4289-4300.
51. Gangappa S., Deshpande S.P., Rouse B.T. Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection. Eur. J. Immunol. 1999, 29:3674-3682.
52. Gangappa S., Deshpande S.P., Rouse B.T. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. Invest. Ophthalmol. Vis. Sci. 2000, 41:453-459.
53. Gardella T., Medveczky P., Sairenji T., Mulder C. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 1984, 50:248-254.
54. Gebhardt B.M., Halford W.P. Evidence that spontaneous reactivation of herpes virus does not occur in mice. Virol. J. 2005, 2:67.
55. Gebhardt B.M., Hill J.M. T lymphocytes in the trigeminal ganglia of rabbits during corneal HSV infection. Invest. Ophthalmol. Vis. Sci. 1988, 29:1683-1691.
56. Gebhardt T., Wakim L.M., Eidsmo L., Reading P.C., Heath W.R., Carbone F.R. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 2009, 10:524-530.
57. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
58. Ghiasi H., Cai S., Slanina S., Nesburn A.B., Wechsler S.L. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral. Res. 1995, 28:147-157.
59. Ghiasi H., Wechsler S.L., Cai S., Nesburn A.B., Hofman F.M. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology 1998, 95:352-359.
60. Ghiasi H., Cai S., Perng G.C., Nesburn A.B., Wechsler S.L. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral. Res. 2000, 45:33-45.
61. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 2005, 5:243-251.
62. Goldsmith K., Chen W., Johnson D.C., Hendricks R.L. Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J. Exp. Med. 1998, 187:341-348.
63. Green L.K., Pavan-Langston D. Herpes simplex ocular inflammatory disease. Int. Ophthalmol. Clin. 2006, 46:27-37.
64. Groom J.R., Luster A.D. CXCR3 in T cell function. Exp. Cell. Res. 2011, 317:620-631.
65. Groom J.R., Luster A.D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell. Biol. 2011, 89:207-215.
66. Hamrah P., Huq S.O., Liu Y., Zhang Q., Dana M.R. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J. Leukoc. Biol. 2003, 74:172-178.
67. Hamrah P., Liu Y., Zhang Q., Dana M.R. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest. Ophthalmol. Vis. Sci. 2003, 44:581-589.
68. Hayashi K., Hooper L.C., Chin M.S., Nagineni C.N., Detrick B., Hooks J.J. Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J. Gen. Virol. 2006, 87:2161-2169.
69. Henderson G., Peng W., Jin L., Perng G.C., Nesburn A.B., Wechsler S.L., Jones C. Regulation of caspase 8- and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript. J. Neurovirol. 2002, 8(Suppl. 2):103-111.
70. Hendricks R.L., Janowicz M., Tumpey T.M. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J. Immunol. 1992, 148:2522-2529.
71. Hendricks R.L., Tumpey T.M., Finnegan A. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 1992, 149:3023-3028.
72. Herpetic Eye Disease Study Group Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N. Engl. J. Med. 1998, 339:300-306.
73. Hill J.M., Clement C. Herpes simplex virus type 1 DNA in human corneas: what are the virological and clinical implications?. J. Infect. Dis. 2009, 200:1-4.
74. Himmelein S., St Leger A.J., Knickelbein J.E., Rowe A., Freeman M.L., Hendricks R.L. Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia. Herpesviridae 2011, 2:5.
75. Hirakawa S., Brown L.F., Kodama S., Paavonen K., Alitalo K., Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007, 109:1010-1017.
76. Holland E.J., Schwartz G.S. Classification of herpes simplex virus keratitis. Cornea 1999, 18:144-154.
77. Hunter C.A., Gabriel K.E., Radzanowski T., Neyer L.E., Remington J.S. Type I interferons enhance production of IFN-gamma by NK cells. Immunol. Lett. 1997, 59:1-5.
78. Huster K.M., Panoutsakopoulou V., Prince K., Sanchirico M.E., Cantor H. T cell-dependent and -independent pathways to tissue destruction following herpes simplex virus-1 infection. Eur. J. Immunol. 2002, 32:1414-1419.
79. Janeway C. Immunobiology: the Immune System in Health and Disease 2005, Garland Science, New York. sixth ed.
80. Jiang X., Chentoufi A.A., Hsiang C., Carpenter D., Osorio N., BenMohamed L., Fraser N.W., Jones C., Wechsler S.L. The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing. J. Virol. 2011, 85:2325-2332.
81. Jones B.R. The clinical features of viral keratitis and a concept of their pathogenesis. Proc. R. Soc. Med. 1958, 51:917-924.
82. Kanangat S., Thomas J., Gangappa S., Babu J.S., Rouse B.T. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J. Immunol. 1996, 156:1110-1116.
83. Kasman L.M., Biber J.M., Vroman D.T. Immunoglobulin gene implicated in murine herpes stromal keratitis is not associated with the human disease. Cornea 2006, 25:1069-1071.
84. Kassim S.H., Rajasagi N.K., Ritz B.W., Pruett S.B., Gardner E.M., Chervenak R., Jennings S.R. Dendritic cells are required for optimal activation of natural killer functions following primary infection with herpes simplex virus type 1. J. Virol. 2009, 83:3175-3186.
85. Kastrukoff L.F., Lau A.S., Takei F., Smyth M.J., Jones C.M., Clarke S.R., Carbone F.R. Redundancy in the immune system restricts the spread of HSV-1 in the central nervous system (CNS) of C57BL/6 mice. Virology 2010, 400:248-258.
86. Kaufman H.E., Azcuy A.M., Varnell E.D., Sloop G.D., Thompson H.W., Hill J.M. HSV-1 DNA in tears and saliva of normal adults. Invest. Ophthalmol. Vis. Sci. 2005, 46:241-247.
87. Kaye S., Choudhary A. Herpes simplex keratitis. Prog. Retin. Eye Res. 2006, 25:355-380.
88. Kaye S.B., Baker K., Bonshek R., Maseruka H., Grinfeld E., Tullo A., Easty D.L., Hart C.A. Human herpesviruses in the cornea. Br. J. Ophthalmol. 2000, 84:563-571.
89. Keadle T.L., Laycock K.A., Morris J.L., Leib D.A., Morrison L.A., Pepose J.S., Stuart P.M. Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice. J. Gen. Virol. 2002, 83:2361-2365.
90. Khanna K.M., Bonneau R.H., Kinchington P.R., Hendricks R.L. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 2003, 18:593-603.
91. Kim B., Tang Q., Biswas P.S., Xu J., Schiffelers R.M., Xie F.Y., Ansari A.M., Scaria P.V., Woodle M.C., Lu P., et al. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am. J. Pathol. 2004, 165:2177-2185.
92. Kim J.Y., Mandarino A., Chao M.V., Mohr I., Wilson A.C. Transient reversal of episome silencing precedes VP16-dependent transcription during reactivation of latent HSV-1 in neurons. PLoS Pathog. 2012, 8:e1002540.
93. Knickelbein J.E., Khanna K.M., Yee M.B., Baty C.J., Kinchington P.R., Hendricks R.L. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 2008, 322:268-271.
94. Knickelbein J.E., Hendricks R.L., Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv. Ophthalmol. 2009, 54:226-234.
95. Knickelbein J.E., Watkins S.C., McMenamin P.G., Hendricks R.L. Stratification of antigen-presenting cells within the normal cornea. Ophthalmol. Eye Dis. 2009, 1:45-54.
96. Kodukula P., Liu T., Rooijen N.V., Jager M.J., Hendricks R.L. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol. 1999, 162:2895-2905.
97. Koelle D.M., Corey L. Recent progress in herpes simplex virus immunobiology and vaccine research. Clin. Microbiol. Rev. 2003, 16:96-113.
98. Komatsu K., Miyazaki D., Morohoshi K., Kuo C.H., Kakimaru-Hasegawa A., Komatsu N., Namba S., Haino M., Matsushima K., Inoue Y. Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice. Curr. Eye Res. 2008, 33:736-749.
99. Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103:1433-1437.
100. Kumaraguru U., Davis I., Rouse B.T. Chemokines and ocular pathology caused by corneal infection with herpes simplex virus. J. Neurovirol. 1999, 5:42-47.
101. Labetoulle M., Auquier P., Conrad H., Crochard A., Daniloski M., Bouee S., El Hasnaoui A., Colin J. Incidence of herpes simplex virus keratitis in France. Ophthalmology 2005, 112:888-895.
102. Lang A., Nikolich-Zugich J. Development and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection. J. Immunol. 2005, 174:2919-2925.
103. Laycock K.A., Lee S.F., Brady R.H., Pepose J.S. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Invest. Ophthalmol. Vis. Sci. 1991, 32:2741-2746.
104. Lee I., Wang L., Wells A.D., Ye Q., Han R., Dorf M.E., Kuziel W.A., Rollins B.J., Chen L., Hancock W.W. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J. Immunol. 2003, 171:6929-6935.
105. Lee S.K., Choi B.K., Kang W.J., Kim Y.H., Park H.Y., Kim K.H., Kwon B.S. MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis. Mol. Cell. 2008, 26:67-73.
106. Lee H.K., Zamora M., Linehan M.M., Iijima N., Gonzalez D., Haberman A., Iwasaki A. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J. Exp. Med. 2009, 206:359-370.
107. Leib D.A., Harrison T.E., Laslo K.M., Machalek M.A., Moorman N.J., Virgin H.W. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 1999, 189:663-672.
108. Leo N.A., Bonneau R.H. Mechanisms underlying chemical sympathectomy-induced suppression of herpes simplex virus-specific cytotoxic T lymphocyte activation and function. J. Neuroimmunol. 2000, 110:45-56.
109. Lepisto A.J., Frank G.M., Xu M., Stuart P.M., Hendricks R.L. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice. Invest. Ophthalmol. Vis. Sci. 2006, 47:3400-3409.
110. Liesegang T.J. Epidemiology and natural history of ocular herpes simplex virus infection in Rochester, Minnesota, 1950-1982. Trans. Am. Ophthalmol. Soc. 1988, 86:688-724.
111. Liesegang T.J. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch. Ophthalmol. 1989, 107:1160-1165.
112. Liesegang T.J. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 1999, 18:127-143.
113. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 2001, 20:1-13.
114. Liesegang T.J., Melton L.J., Daly P.J., Ilstrup D.M. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch. Ophthalmol. 1989, 107:1155-1159.
115. Lima G.K., Zolini G.P., Mansur D.S., Freire Lima B.H., Wischhoff U., Astigarraga R.G., Dias M.F., das Gracas Almeida Silva M., Bela S.R., do Valle Antonelli L.R., et al. Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection. Am. J. Pathol. 2010, 177:2433-2445.
116. Lin M., Carlson E., Diaconu E., Pearlman E. CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis. J. Leukoc. Biol. 2007, 81:786-792.
117. Liu T., Tang Q., Hendricks R.L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 1996, 70:264-271.
118. Liu T., Khanna K.M., Chen X., Fink D.J., Hendricks R.L. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 2000, 191:1459-1466.
119. Liu T., Khanna K.M., Carriere B.N., Hendricks R.L. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 2001, 75:11178-11184.
120. Luker G.D., Prior J.L., Song J., Pica C.M., Leib D.A. Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J. Virol. 2003, 77:11082-11093.
121. Lundberg P., Welander P., Han X., Cantin E. Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo. J. Virol. 2003, 77:11158-11169.
122. Maertzdorf J., Osterhaus A.D., Verjans G.M. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J. Immunol. 2002, 169:5897-5903.
123. Margolis T.P., Dawson C.R., LaVail J.H. Herpes simplex viral infection of the mouse trigeminal ganglion. Immunohistochemical analysis of cell populations. Invest. Ophthalmol. Vis. Sci. 1992, 33:259-267.
124. Margolis T.P., Imai Y., Yang L., Vallas V., Krause P.R. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J. Virol. 2007, 81:1872-1878.
125. Matsuzaki J., Tsuji T., Chamoto K., Takeshima T., Sendo F., Nishimura T. Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. Cell. Immunol. 2003, 224:98-105.
126. McLean C.S., Ni Challanain D., Duncan I., Boursnell M.E., Jennings R., Inglis S.C. Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine. Vaccine 1996, 14:987-992.
127. Mercadal C.M., Bouley D.M., DeStephano D., Rouse B.T. Herpetic stromal keratitis in the reconstituted scid mouse model. J. Virol. 1993, 67:3404-3408.
128. Mikloska Z., Bosnjak L., Cunningham A.L. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 2001, 75:5958-5964.
129. Miller J.K., Laycock K.A., Umphress J.A., Hook K.K., Stuart P.M., Pepose J.S. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice. Cornea 1996, 15:497-504.
130. Miyazaki D., Haruki T., Takeda S., Sasaki S., Yakura K., Terasaka Y., Komatsu N., Yamagami S., Touge H., Touge C., et al. Herpes simplex virus type 1-induced transcriptional networks of corneal endothelial cells indicate antigen presentation function. Invest. Ophthalmol. Vis. Sci. 2011, 52:4282-4293.
131. Mogensen S.C. Role of macrophages in natural resistance to virus infections. Microbiol. Rev. 1979, 43:1-26.
132. Molesworth-Kenyon S.J., Yin R., Oakes J.E., Lausch R.N. IL-17 receptor signaling influences virus-induced corneal inflammation. J. Leukoc. Biol. 2008, 83:401-408.
133. Mott K., Brick D.J., van Rooijen N., Ghiasi H. Macrophages are important determinants of acute ocular HSV-1 infection in immunized mice. Invest. Ophthalmol. Vis. Sci. 2007, 48:5605-5615.
134. Nakamura T., Ishikawa F., Sonoda K.H., Hisatomi T., Qiao H., Yamada J., Fukata M., Ishibashi T., Harada M., Kinoshita S. Characterization and distribution of bone marrow-derived cells in mouse cornea. Invest. Ophthalmol. Vis. Sci. 2005, 46:497-503.
135. Nakano H., Yanagita M., Gunn M.D. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 2001, 194:1171-1178.
136. Newell C.K., Martin S., Sendele D., Mercadal C.M., Rouse B.T. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J. Virol. 1989, 63:769-775.
137. Newell C.K., Sendele D., Rouse B.T. Effects of CD4+ and CD8+ T-lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis. Reg. Immunol. 1989, 2:366-369.
138. Nicholls S.M., Shimeld C., Easty D.L., Hill T.J. Recurrent herpes simplex after corneal transplantation in rats. Invest. Ophthalmol. Vis. Sci. 1996, 37:425-435.
139. Oakes J.E., Monteiro C.A., Cubitt C.L., Lausch R.N. Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells. J. Virol. 1993, 67:4777-4784.
140. Ohara P.T., Chin M.S., LaVail J.H. The spread of herpes simplex virus type 1 from trigeminal neurons to the murine cornea: an immunoelectron microscopy study. J. Virol. 2000, 74:4776-4786.
141. Ohashi Y., Yamamoto S., Nishida K., Okamoto S., Kinoshita S., Hayashi K., Manabe R. Demonstration of herpes simplex virus DNA in idiopathic corneal endotheliopathy. Am. J. Ophthalmol. 1991, 112:419-423.
142. Openshaw H., Asher L.V., Wohlenberg C., Sekizawa T., Notkins A.L. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation. J. Gen. Virol. 1979, 44:205-215.
143. Openshaw H., McNeill J.I., Lin X.H., Niland J., Cantin E.M. Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia. J. Med. Virol. 1995, 46:75-80.
144. Osorio Y., Wechsler S.L., Nesburn A.B., Ghiasi H. Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice. Virus. Res. 2002, 90:317-326.
145. Padgett D.A., Glaser R. How stress influences the immune response. Trends Immunol. 2003, 24:444-448.
146. Padgett D.A., Sheridan J.F., Dorne J., Berntson G.G., Candelora J., Glaser R. Social stress and the reactivation of latent herpes simplex virus type 1. Proc. Natl. Acad. Sci. U S A 1998, 95:7231-7235.
147. Palamara F., Meindl S., Holcmann M., Luhrs P., Stingl G., Sibilia M. Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J. Immunol. 2004, 173:3051-3061.
148. Pavan-Langston D., Foster C.S. Trifluorothymidine and idoxuridine therapy of ocular herpes. Am. J. Ophthalmol. 1977, 84:818-825.
149. Perng G.C., Jones C., Ciacci-Zanella J., Stone M., Henderson G., Yukht A., Slanina S.M., Hofman F.M., Ghiasi H., Nesburn A.B., et al. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 2000, 287:1500-1503.
150. Pollara G., Jones M., Handley M.E., Rajpopat M., Kwan A., Coffin R.S., Foster G., Chain B., Katz D.R. Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion. J. Immunol. 2004, 173:4108-4119.
151. Porter S.M., Patterson A., Kho P. A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis. Br. J. Ophthalmol. 1990, 74:283-285.
152. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., Koch A.E., Moser B., Mackay C.R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 1998, 101:746-754.
153. Rabenau H.F., Buxbaum S., Preiser W., Weber B., Doerr H.W. Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med. Microbiol. Immunol. 2002, 190:153-160.
154. Remeijer L., Duan R., van Dun J.M., Wefers Bettink M.A., Osterhaus A.D., Verjans G.M. Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. J. Infect. Dis. 2009, 200:11-19.
155. Roizman B., Zhou G., Du T. Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues. J. Neurovirol. 2011, 17:512-517.
156. Russell R.G., Nasisse M.P., Larsen H.S., Rouse B.T. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 1984, 25:938-944.
157. Sainz B., Loutsch J.M., Marquart M.E., Hill J.M. Stress-associated immunomodulation and herpes simplex virus infections. Med. Hypotheses. 2001, 56:348-356.
158. Sawtell N.M., Thompson R.L. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol. 1992, 66:2150-2156.
159. Schall T.J., Bacon K., Toy K.J., Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990, 347:669-671.
160. Sciammas R., Kodukula P., Tang Q., Hendricks R.L., Bluestone J.A. T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J. Exp. Med. 1997, 185:1969-1975.
161. Shah A., Farooq A.V., Tiwari V., Kim M.J., Shukla D. HSV-1 infection of human corneal epithelial cells: receptor-mediated entry and trends of re-infection. Mol. Vis. 2010, 16:2476-2486.
162. Sheridan B.S., Cherpes T.L., Urban J., Kalinski P., Hendricks R.L. Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes. J. Virol. 2009, 83:2237-2245.
163. Shimeld C., Hill T.J., Blyth W.A., Easty D.L. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. J. Gen. Virol. 1990, 71(Pt. 3):681-687.
164. Shimeld C., Hill T.J., Blyth W.A., Easty D.L. Reactivation of latent infection and induction of recurrent herpetic eye disease in mice. J. Gen. Virol. 1990, 71(Pt. 2):397-404.
165. Skobe M., Dana R. Blocking the path of lymphatic vessels. Nat. Med. 2009, 15:993-994.
166. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 2001, 7:192-198.
167. Spencer W.H., Hayes T.L. Scanning and transmission electron microscopic observations of the topographic anatomy of dendritic lesions in the rabbit cornea. Invest. Ophthalmol. 1970, 9:183-195.
168. Sprecher E., Becker Y. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity. Arch. Virol. 1989, 107:191-205.
169. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 1973, 137:1142-1162.
170. Steinman R.M., Gutchinov B., Witmer M.D., Nussenzweig M.C. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J. Exp. Med. 1983, 157:613-627.
171. Su Y.H., Yan X.T., Oakes J.E., Lausch R.N. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J. Virol. 1996, 70:1277-1281.
172. Suryawanshi A., Veiga-Parga T., Rajasagi N.K., Reddy P.B., Sehrawat S., Sharma S., Rouse B.T. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J. Immunol. 2011, 187:1919-1930.
173. Suryawanshi A., Veiga-Parga T., Reddy P.B., Rajasagi N.K., Rouse B.T. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J. Immunol. 2012, 188:3434-3446.
174. Takeda S., Miyazaki D., Sasaki S., Yamamoto Y., Terasaka Y., Yakura K., Yamagami S., Ebihara N., Inoue Y. Roles played by toll-like receptor-9 in corneal endothelial cells after herpes simplex virus type 1 infection. Invest. Ophthalmol. Vis. Sci. 2011, 52:6729-6736.
175. Tang Q., Chen W., Hendricks R.L. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J. Immunol. 1997, 158:1275-1283.
176. Tang S., Patel A., Krause P.R. Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs. J. Virol. 2009, 83:1433-1442.
177. Terasaka Y., Miyazaki D., Yakura K., Haruki T., Inoue Y. Induction of IL-6 in transcriptional networks in corneal epithelial cells after herpes simplex virus type 1 infection. Invest. Ophthalmol. Vis. Sci. 2009, 51:2441-2449.
178. The Collaborative Corneal Transplantation Studies Research Group The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch. Ophthalmol. 1992, 110:1392-1403.
179. Theil D., Derfuss T., Paripovic I., Herberger S., Meinl E., Schueler O., Strupp M., Arbusow V., Brandt T. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 2003, 163:2179-2184.
180. Thomas J., Gangappa S., Kanangat S., Rouse B.T. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 1997, 158:1383-1391.
181. Tumpey T.M., Chen S.H., Oakes J.E., Lausch R.N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 1996, 70:898-904.
182. Tumpey T.M., Cheng H., Cook D.N., Smithies O., Oakes J.E., Lausch R.N. Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis. J. Virol. 1998, 72:3705-3710.
183. Tumpey T.M., Cheng H., Yan X.T., Oakes J.E., Lausch R.N. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J. Leukoc. Biol. 1998, 63:486-492.
184. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454:780-783.
185. Valyi-Nagy T., Sheth V., Clement C., Tiwari V., Scanlan P., Kavouras J.H., Leach L., Guzman-Hartman G., Dermody T.S., Shukla D. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye. Curr. Eye Res. 2004, 29:303-309.
186. Verjans G.M., Remeijer L., van Binnendijk R.S., Cornelissen J.G., Volker-Dieben H.J., Baarsma S.G., Osterhaus A.D. Identification and characterization of herpes simplex virus-specific CD4+ T cells in corneas of herpetic stromal keratitis patients. J. Infect. Dis. 1998, 177:484-488.
187. Verjans G.M., Remeijer L., Mooy C.M., Osterhaus A.D. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells. Invest. Ophthalmol. Vis. Sci. 2000, 41:2607-2612.
188. Verjans G.M., Hintzen R.Q., van Dun J.M., Poot A., Milikan J.C., Laman J.D., Langerak A.W., Kinchington P.R., Osterhaus A.D. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. U S A 2007, 104:3496-3501.
189. Vicetti Miguel R.D., Sheridan B.S., Harvey S.A., Schreiner R.S., Hendricks R.L., Cherpes T.L. 17-beta estradiol promotion of herpes simplex virus type 1 reactivation is estrogen receptor dependent. J. Virol. 2010, 84:565-572.
190. Vollstedt S., Arnold S., Schwerdel C., Franchini M., Alber G., Di Santo J.P., Ackermann M., Suter M. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J. Virol. 2004, 78:3846-3850.
191. Wakim L.M., Gebhardt T., Heath W.R., Carbone F.R. Cutting edge: local recall responses by memory T cells newly recruited to peripheral nonlymphoid tissues. J. Immunol. 2008, 181:5837-5841.
192. Walzer T., Dalod M., Robbins S.H., Zitvogel L., Vivier E. Natural-killer cells and dendritic cells: " l'union fait la force" Blood 2005, 106:2252-2258.
193. Wang Q.Y., Zhou C., Johnson K.E., Colgrove R.C., Coen D.M., Knipe D.M. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc. Natl. Acad. Sci. U S A 2005, 102:16055-16059.
194. Weber C., Weber K.S., Klier C., Gu S., Wank R., Horuk R., Nelson P.J. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood 2001, 97:1144-1146.
195. Wilhelmus K.R. Diagnosis and management of herpes simplex stromal keratitis. Cornea 1987, 6:286-291.
196. Williams K.A., Muehlberg S.M., Lewis R.F., Coster D.J. How successful is corneal transplantation? A report from the Australian corneal graft register. Eye 1995, 9(Pt. 2):219-227.
197. Williams K.A., Muehlberg S.M., Lewis R.F., Coster D.J. Long-term outcome in corneal allotransplantation. The Australian corneal graft registry. Transplant. Proc. 1997, 29:983.
198. Wisner T.W., Sugimoto K., Howard P.W., Kawaguchi Y., Johnson D.C. Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms. J. Virol. 2011, 85:5919-5928.
199. Wojtasiak M., Pickett D.L., Tate M.D., Londrigan S.L., Bedoui S., Brooks A.G., Reading P.C. Depletion of Gr-1+, but not Ly6G+, immune cells exacerbates virus replication and disease in an intranasal model of herpes simplex virus type 1 infection. J. Gen. Virol. 2010, 91:2158-2166.
200. Wuest T.R., Carr D.J. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. J. Immunol. 2008, 181:7985-7993.
201. Wuest T.R., Carr D.J. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 2010, 207:101-115.
202. Wuest T., Farber J., Luster A., Carr D.J. CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell. Immunol. 2006, 243:83-89.
203. Wuest T., Zheng M., Efstathiou S., Halford W.P., Carr D.J. The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization. PLoS Pathog. 2011, 7:e1002278.
204. Wuest T.R., Thapa M., Zheng M., Carr D.J. CXCL10 expressing hematopoietic-derived cells are requisite in defense against HSV-1 infection in the nervous system of CXCL10 deficient mice. J. Neuroimmunol. 2011, 234:103-108.
205. Xu F., Sternberg M.R., Kottiri B.J., McQuillan G.M., Lee F.K., Nahmias A.J., Berman S.M., Markowitz L.E. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. J. Am. Med. Assoc. 2006, 296:964-973.
206. Yan X.T., Tumpey T.M., Kunkel S.L., Oakes J.E., Lausch R.N. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest. Ophthalmol. Vis. Sci. 1998, 39:1854-1862.
207. Yang L., Voytek C.C., Margolis T.P. Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. J. Virol. 2000, 74:209-217.
208. Young R.C., Hodge D.O., Liesegang T.J., Baratz K.H. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis. Arch. Ophthalmol. 2010, 128:1178-1183.
209. Zhao Z.S., Granucci F., Yeh L., Schaffer P.A., Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998, 279:1344-1347.
210. Zhao X., Deak E., Soderberg K., Linehan M., Spezzano D., Zhu J., Knipe D.M., Iwasaki A. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 2003, 197:153-162.
211. Zheng X., Loutsch J.M., Shimomura Y., Gebhardt B.M., Hill J.M., Kaufman H.E. Reactivation of herpes virus after lamellar keratoplasty. Jpn. J. Ophthalmol. 1999, 43:257-261.
212. Zheng M., Deshpande S., Lee S., Ferrara N., Rouse B.T. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 2001, 75:9828-9835.
213. Zheng M., Schwarz M.A., Lee S., Kumaraguru U., Rouse B.T. Control of stromal keratitis by inhibition of neovascularization. Am. J. Pathol. 2001, 159:1021-1029.
214. Zheng M., Klinman D.M., Gierynska M., Rouse B.T. DNA containing CpG motifs induces angiogenesis. Proc. Natl. Acad. Sci. U S A 2002, 99:8944-8949.
215. Zhu J., Koelle D.M., Cao J., Vazquez J., Huang M.L., Hladik F., Wald A., Corey L. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J. Exp. Med. 2007, 204:595-603.